was read the article
array:23 [ "pii" => "S0301054611001534" "issn" => "03010546" "doi" => "10.1016/j.aller.2011.02.010" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "aid" => "286" "copyright" => "SEICAP" "copyrightAnyo" => "2011" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2012;40:75-80" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2128 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 1656 "PDF" => 465 ] ] "itemSiguiente" => array:18 [ "pii" => "S030105461100156X" "issn" => "03010546" "doi" => "10.1016/j.aller.2011.02.012" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "aid" => "289" "copyright" => "SEICAP" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2012;40:81-7" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 2218 "formatos" => array:3 [ "EPUB" => 6 "HTML" => 1767 "PDF" => 445 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "T-cell proliferation by surface molecules expression on polymorphonuclear neutrophils stimulated with IL-4 in superantigen presence" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "81" "paginaFinal" => "87" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0020" "etiqueta" => "Figure 4" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr4.jpeg" "Alto" => 2062 "Ancho" => 3243 "Tamanyo" => 138547 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0045" class="elsevierStyleSimplePara elsevierViewall">Changes in HLA class II (A), CD80 (B) and CD86 (C) expression on unstimulated and IL-4 stimulated PMN. Statistical analysis showed that, there is a significant difference between IL-4 stimulated cells and unstimulated cells, <span class="elsevierStyleItalic">P</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B.K.A. Abdel-Salam" "autores" => array:1 [ 0 => array:2 [ "nombre" => "B.K.A." "apellidos" => "Abdel-Salam" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S030105461100156X?idApp=UINPBA00004N" "url" => "/03010546/0000004000000002/v1_201304101104/S030105461100156X/v1_201304101104/en/main.assets" ] "itemAnterior" => array:18 [ "pii" => "S0301054611001649" "issn" => "03010546" "doi" => "10.1016/j.aller.2011.03.010" "estado" => "S300" "fechaPublicacion" => "2012-03-01" "aid" => "295" "copyright" => "SEICAP" "documento" => "article" "crossmark" => 0 "subdocumento" => "fla" "cita" => "Allergol Immunopathol (Madr). 2012;40:71-4" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:2 [ "total" => 1839 "formatos" => array:3 [ "EPUB" => 5 "HTML" => 1472 "PDF" => 362 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original Article</span>" "titulo" => "A role for measurement of nasal IgE antibodies in diagnosis of <span class="elsevierStyleItalic">Alternaria</span>-induced rhinitis in children" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "71" "paginaFinal" => "74" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "N. Fuiano, S. Fusilli, C. Incorvaia" "autores" => array:3 [ 0 => array:2 [ "nombre" => "N." "apellidos" => "Fuiano" ] 1 => array:2 [ "nombre" => "S." "apellidos" => "Fusilli" ] 2 => array:2 [ "nombre" => "C." "apellidos" => "Incorvaia" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054611001649?idApp=UINPBA00004N" "url" => "/03010546/0000004000000002/v1_201304101104/S0301054611001649/v1_201304101104/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Beneficial effects of erythropoietin on airway histology in a murine model of chronic asthma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "75" "paginaFinal" => "80" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "M. Karaman, F. Firinci, M. Kiray, T. Tuncel, A. Bagriyanik, O. Yilmaz, N. Uzuner, O. Karaman" "autores" => array:8 [ 0 => array:3 [ "nombre" => "M." "apellidos" => "Karaman" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "F." "apellidos" => "Firinci" "email" => array:2 [ 0 => "fatih.firinci@deu.edu.tr" 1 => "fatihfirinci@yahoo.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 2 => array:3 [ "nombre" => "M." "apellidos" => "Kiray" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "T." "apellidos" => "Tuncel" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 4 => array:3 [ "nombre" => "A." "apellidos" => "Bagriyanik" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 5 => array:3 [ "nombre" => "O." "apellidos" => "Yilmaz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 6 => array:3 [ "nombre" => "N." "apellidos" => "Uzuner" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 7 => array:3 [ "nombre" => "O." "apellidos" => "Karaman" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Multidisciplinary Laboratory, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey" "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Pediatric Allergy and Immunology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey" "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Department of Histology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey" "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 764 "Ancho" => 2354 "Tamanyo" => 100628 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Murine model of airway inflammation and treatment with EPO.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Asthma is a chronic disease characterised by reversible airway obstruction, airway inflammation, and remodelling.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Current strategies for the management of asthma focus on suppressing airway inflammation, the key factor in the pathogenesis of asthma.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> Airway remodelling, a potentially important consequence of asthma, comprises progressive structural changes in the composition, content, and organisation of the cellular and molecular constituents of the airway wall, as well as enhanced turnover of extracellular matrix components.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> It includes goblet cell hyperplasia, basement membrane thickening, subepithelial fibrosis, airway smooth muscle hypertrophy/hyperplasia, and angiogenesis.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Airway remodelling is poorly responsive to current anti-inflammatory asthma therapies, including inhaled corticosteroids and antileukotrienes.<a class="elsevierStyleCrossRefs" href="#bib0025"><span class="elsevierStyleSup">5,6</span></a> Thus, new therapeutic options are required.</p><p id="par0010" class="elsevierStylePara elsevierViewall">Erythropoietin (EPO), a 30.4-kD glycoprotein that regulates the rate of red blood cell production through binding to its specific cell surface receptors, has been used for many years for the treatment of anaemia.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> EPO has pleiotropic actions including antioxidant, anti-apoptotic, anti-inflammatory and angiogenic effects. Antioxidant effect of EPO is via decreasing plasma iron concentration and increasing the capability of plasma in inhibition of lipid peroxidation.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">7–10</span></a> EPO also inhibits the synthesis of IL-4, IL-5.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> Thus, given the abovementioned effects, EPO may have a role in the treatment of asthma. However, the accurate benefits of EPO in asthma treatment have not been investigated yet. Therefore, in this study our aim is to investigate the efficacy of EPO on lung histopathology in a murine model of chronic asthma.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Materials and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Experimental animals</span><p id="par0015" class="elsevierStylePara elsevierViewall">Specific pathogen-free, 6- to 8-week-old, female BALB/c mice, weighting 18–20<span class="elsevierStyleHsp" style=""></span>g, were maintained in a pathogen-free laboratory of Dokuz Eylul University. They were kept in hygienic macrolene cages in air-conditioned rooms and allowed ad libitum with food and water on a 12-h light/12-h dark cycle. All experimental procedures complied with the requirements of the Animal Care and Ethics Committee of the Dokuz Eylul University. Thirty-five BALB/c mice were divided into five groups: I, II, III, IV, and control group, each group included seven mice.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Sensitisation and inhalational exposure</span><p id="par0020" class="elsevierStylePara elsevierViewall">BALB/c mice are high responders to ovalbumin.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> The mice in study groups I, II, III, and IV were sensitised via two intraperitoneal injections, on days 0 and 14 of the experiment, of 10<span class="elsevierStyleHsp" style=""></span>μg/0.1<span class="elsevierStyleHsp" style=""></span>mL chicken egg albumin (ovalbumin, grade V, ≥98% pure; Sigma, St. Louis, MO, USA) with alum as an adjuvant. The mice in study groups I, II, III, and IV were then exposed to aerosolised ovalbumin for 30<span class="elsevierStyleHsp" style=""></span>min per day on three days of a week for eight weeks, beginning from the 21st day of the study (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Exposures were carried out in a whole body inhalation exposure system. Temperature and relative humidity were maintained between 20–25<span class="elsevierStyleHsp" style=""></span>°C and 40–60%, respectively. A solution of 2.5% ovalbumin in normal saline was delivered by aerosolisation via compressed air to a sidestream jet nebuliser injected into a chamber. The aerosol generated by this nebuliser comprised >80% particles with a diameter of <4<span class="elsevierStyleHsp" style=""></span>μm. Particle concentration was maintained in the range of 10–20<span class="elsevierStyleHsp" style=""></span>mg/mm<span class="elsevierStyleSup">3</span>.<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a></p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0025" class="elsevierStylePara elsevierViewall">The mice in the control group were administered normal saline with alum via intraperitoneally on the 0 and 14th days of the experiment and exposed aerosolised saline for 30<span class="elsevierStyleHsp" style=""></span>min per day on three days of the week for eight weeks, beginning from the 21st day of the study.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12,13</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Study drugs</span><p id="par0030" class="elsevierStylePara elsevierViewall">Mice in Group I received saline; Group II received EPO at dose of 500<span class="elsevierStyleHsp" style=""></span>IU/kg; Group III received EPO at dose of 1000<span class="elsevierStyleHsp" style=""></span>IU/kg; and Group IV dexamethasone at dose of 1<span class="elsevierStyleHsp" style=""></span>mg/kg intraperitoneally once a day in the last five days of the challenge period. Intraperitoneal doses of human recombinant EPO (Epoetin alpha, Eprex, Roche) and dexamethasone 1<span class="elsevierStyleHsp" style=""></span>mg/kg were chosen from other studies also conducted with BALB/c mice.<a class="elsevierStyleCrossRefs" href="#bib0065"><span class="elsevierStyleSup">13–15</span></a></p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Histopathological analysis</span><p id="par0035" class="elsevierStylePara elsevierViewall">Animals were sacrificed by an overdose of ketamine 24<span class="elsevierStyleHsp" style=""></span>h after the last drug administration. Two investigators who were blinded to the treatment groups interpreted the histopathology. Tissue specimens were obtained from the mid zone of the left lung of mice. Samples were fixed in 10% formalin for light microscopic evaluation. Some tissue samples of 1–2<span class="elsevierStyleHsp" style=""></span>mm<span class="elsevierStyleSup">3</span> obtained from adjacent regions were stocked in 2.5% gluteraldehyde for electron microscopic evaluation. After fixation, samples were embedded in paraffin for light microscopic evaluation and serial sections of 5-μm thickness were prepared. After choosing the first section randomly, 10 sections in each mouse were selected by skipping over 10 sections and proceeded to staining process. For light microscopic evaluation, three different staining processes were used. The first 10 samples were stained with haematoxylin and eosin (H&E). In these samples, general tissue features were examined and thicknesses of epithelium and subepithelial smooth muscle layers of the medium and small airways were measured. In order to evaluate the thicknesses of epithelium and subepithelial smooth muscle layers, measurements were performed from four points of each airway at levels of 3, 6, 9, and 12<span class="elsevierStyleHsp" style=""></span>o’clock. Considering that each section contained approximately two to three airways, around 20 or more airways were evaluated for each mouse.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Photomicrographs were taken by JVC TK-890-E camera (Japan), which was adapted on Olympus BH-2 RFCA model microscope (Olympus Optical, Tokyo, Japan). The histological analysis was carried out with UTHSCSA Image Tool for Windows Version 3.00 software.</p><p id="par0045" class="elsevierStylePara elsevierViewall">The consecutive 10 sections were stained with toluidine blue and the other 10 sections with periodic acid-Schiff (PAS). Photomicrographs were taken randomly from five fields of each section which were stained with toluidine blue. For mast cell enumeration, a standard transparent counting frame representing an area of 20,000<span class="elsevierStyleHsp" style=""></span>μm<span class="elsevierStyleSup">2</span> was used manually and eight fields in each photograph were examined for each mouse. Goblet cells stained with PAS were enumerated in 10 sections of each mouse. In each section, three to five randomly selected airways were photographed. Circumferences of all airways were measured and goblet cell numbers in these areas were recorded. For standardisation, goblet cell numbers in 100<span class="elsevierStyleHsp" style=""></span>μm were analysed by division of total goblet cell number to the total length of airway circumferences and multiplying the result by one hundred.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Tissues were embedded in EPON after follow-up process of electron microscopic evaluation. Airways were marked from the semithin sections by light microscope. Ultrathin sections were obtained and stained with uraniyl acetate and lead citrate. Libra 120 Carl Zeiss EFTEM electron microscope (Oberkochen, Germany) was used for this evaluation. For each mouse, five to seven ultrathin sections were achieved from each two blocks for evaluation of epithelium of the airway, the surrounding structures, and the intercellular connections.</p><p id="par0055" class="elsevierStylePara elsevierViewall">For each mouse, eight to ten areas were photographed by Trondle (2048<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>2048 pixel) digital camera, attached to the electron microscope. Thicknesses of the basement membrane of the respiratory epithelium were measured from 20 points of preparations at equal distances to each other and the data were recorded in sequence.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Statistical analysis</span><p id="par0060" class="elsevierStylePara elsevierViewall">SPSS 11 package program was used for the statistical analysis. Data were presented as mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>standard deviation (SD) (minimum–maximum) of seven animals in each group. The comparisons between all groups were conducted by using Kruskal–Wallis method. When differences were statistically significant, Mann–Whitney <span class="elsevierStyleItalic">U</span> test was used for group comparisons. <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was considered statistically significant.</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Results</span><p id="par0065" class="elsevierStylePara elsevierViewall">The light and electron microscopic examinations revealed normal findings in the control group (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>-I). In the chronic asthma group (placebo), the numbers of mast cells and goblet cells as well as the thicknesses of basement membrane, epithelium, and subepithelial smooth muscle layer were significantly higher when compared to the control group (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). Additionally, <a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>-II demonstrates that characteristic asthmatic changes were successfully established in the group treated with saline (Group I).</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0070" class="elsevierStylePara elsevierViewall">In Group II (EPO 500<span class="elsevierStyleHsp" style=""></span>IU/kg), basement membrane thickness and number of mast cells were significantly lower compared with regard to the group treated with saline (Group I). Both the thicknesses of epithelium and subepithelial muscle layer and the number of goblet cells were similar to that of the group treated with saline (Group I). Additionally, respiratory tract epithelium and ciliary structures were similar to normal airway findings (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a> and <a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>-III).</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0075" class="elsevierStylePara elsevierViewall">When EPO was administered at a dose of 1000<span class="elsevierStyleHsp" style=""></span>IU/kg (Group III), significant improvement occurred in all histological parameters compared with the group treated with saline (Group I). This improvement was similar to dexamethasone, the gold standard treatment of asthma (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). Parenchymal structures and respiratory epithelium were normal (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>-IV).</p><p id="par0080" class="elsevierStylePara elsevierViewall">In Group IV (dexamethasone 1<span class="elsevierStyleHsp" style=""></span>mg/kg), all histological parameters were significantly better compared to the group treated with saline (Group I). Electron microscopic findings demonstrated regular basement membrane and normal ciliary epithelium (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a> and <a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>-V).</p><p id="par0085" class="elsevierStylePara elsevierViewall">When low and high dosages of EPO were compared to each other; all histological parameters were found to be significantly better in the group treated with high dose of EPO (Group III) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>). When EPO groups were compared with dexamethasone group, among all the histological variables, the only significant difference was lower mast cell counts in the group treated with high dose of EPO (Group III) (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05) (<a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>).</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Discussion</span><p id="par0090" class="elsevierStylePara elsevierViewall">Airway inflammation in asthma causes subsequent structural changes called as remodelling.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Structural changes in asthmatic airways occur as a result of an injury/repair process. Currently, drugs used for the treatment of asthma have little effect on airway remodelling.<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> EPO has uncertain value in the treatment of asthma. Although the anti-inflammatory properties of EPO have been reported many times, their effects on remodelling have rarely been evaluated. Thus, we aimed to investigate the efficacy of EPO on lung histological changes and especially on remodelling in a murine model of chronic asthma.</p><p id="par0095" class="elsevierStylePara elsevierViewall">Chronic inflammation in asthma is thought to initiate and perpetuate tissue injury and repair.<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a> In our study, the structural changes observed in the asthmatic group revealed that the model was well established. It seems very important to prevent airway remodelling in the chronic management of asthma,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> because once formed, remodelling is resistant to asthma therapy.<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a> Inhalation of corticosteroids and administration of β<span class="elsevierStyleInf">2</span> agonists, antileukotrienes, and theophylline are poorly responsive to these structural changes. Inhaled corticosteroids may be effective in reducing reticular basement membrane thickness when used for a long period of time and at high doses.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> In our study, dexamethasone and high dose of EPO significantly ameliorated all the structural changes of chronic asthma. This finding is very important because reticular basement membrane thickness is considered a hallmark for airway remodelling in asthma.<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a></p><p id="par0100" class="elsevierStylePara elsevierViewall">EPO is a hormone which maintains erythrocyte mass. The major mechanism for increasing in erythrocyte mass is the prevention of apoptosis of late erythroid progenitor cells.<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a> In the haematopoietic system, the principal function of EPO is the regulation of red blood cell production, mediated by its specific cell surface receptor. Recombinant EPO forms EPO alfa, EPO beta, and long-acting analogue darbepoetin alfa have been widely used for treatment of anaemia in chronic kidney disease and chemotherapy-induced anaemia in cancer patients.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a></p><p id="par0105" class="elsevierStylePara elsevierViewall">Recent studies showed that EPO protects various tissues through antiapoptotic effects. EPO protects the developing brain against N-methylaspartate receptor antagonist induced neuronal cell apoptosis,<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> and inhibits spinal neuronal apoptosis and pain following nerve root crush.<a class="elsevierStyleCrossRef" href="#bib0115"><span class="elsevierStyleSup">23</span></a> EPO also markedly reduced apoptosis of adult rat cardiomyocytes subjected to hypoxia in vitro, and reduced cardiomyocyte loss by 50%.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> In addition, EPO protected tubular epithelial cells against apoptosis induced by ischemic acute renal injury.<a class="elsevierStyleCrossRef" href="#bib0125"><span class="elsevierStyleSup">25</span></a></p><p id="par0110" class="elsevierStylePara elsevierViewall">EPO is a complex anti-inflammatory agent which exerts a wide variety of immunosuppressive effects targeting epithelial cells, neutrophils, T and B lymphocytes, mast cells, natural killer cells, and endothelial cells. Additionally, EPO has an inhibiting effect on the synthesis of some inflammatory cytokines such as IL-4, IL-5.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> IL-4, IL-5 are important mediators in pathogenesis of asthma. We considered that EPO, especially at a higher dose, showed beneficial results owing to its anti-inflammatory and anti-reactive oxygen species effects. Due to the delayed expression of EPO gene after the injury and the suppression of EPO production by inflammatory cytokines, just exogenous EPO can be protective against the inflammation.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a></p><p id="par0115" class="elsevierStylePara elsevierViewall">NF-κB is a family of DNA-binding protein factors that have an important role for the transcription of pro-inflammatory molecules.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> So, NF-κB can be a basic mediator in the pathogenesis of asthma. The inhibition of NF-κB causes the reduction of allergic lung inflammation and airway hyperresponsiveness.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> NF-κB-binding activity in bronchial mucosa biopsy samples of asthmatic patients was reduced with inhaled budesonide treatment.<a class="elsevierStyleCrossRef" href="#bib0145"><span class="elsevierStyleSup">29</span></a> Consequently the inhibition of NF-κB has an important role for the control of pulmonary inflammation.<a class="elsevierStyleCrossRef" href="#bib0140"><span class="elsevierStyleSup">28</span></a> In recent studies, it was demonstrated that EPO reduces the production of NF-κB-inducible immune mediators.<a class="elsevierStyleCrossRef" href="#bib0150"><span class="elsevierStyleSup">30</span></a> In our study, EPO may reduce the inflammation with the helping of inhibited NF-κB.</p><p id="par0120" class="elsevierStylePara elsevierViewall">The basic mediators of injury are reactive free radicals produced by cellular metabolism under hypoxic condition. Hypoxia leads to synthesis of the hypoxia inducible factor family protein genes, including EPO.<a class="elsevierStyleCrossRef" href="#bib0130"><span class="elsevierStyleSup">26</span></a> Cuzzocrea et al. previously demonstrated that EPO reduced arthritis caused by type II collagen in mice, partly by decreasing free radical production.<a class="elsevierStyleCrossRef" href="#bib0155"><span class="elsevierStyleSup">31</span></a> EPO significantly reduced the ultrastructural pathological changes and levels of lipid peroxidation in lung tissues after traumatic brain injury. Reactive oxygen species and nitric oxide have been demonstrated to be involved in the pathogenesis of bleomycin-induced pulmonary fibrosis in rodents.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> EPO may therefore also be beneficial against lung injury and fibrosis as an antioxidant agent.</p><p id="par0125" class="elsevierStylePara elsevierViewall">There were some limitations of our study, such as the fact that cytokine levels could not be evaluated and the results found in our study may not translate to positive findings in human clinical trials. Here, to determine the effect of EPO in the treatment of chronic asthma, we evaluated only histopathological changes. Most of the asthma models are devoid of the chronic histopathological changes seen in human asthma because of short term exposure to inhaled antigen. Temelkovski et al. suggested that this experimental model replicated many features of human asthma.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> By the same model, a progressive inflammatory response was developed in the airways of mice characterised by the presence of intraepithelial eosinophils and by infiltration of the lamina propria with lymphoid, mononuclear cells. Goblet cell hyperplasia, epithelial thickening, and subepithelial fibrosis were also evident. Although we could only evaluate the histopathological changes of asthma, the validity of our method increases the value of our study.</p><p id="par0130" class="elsevierStylePara elsevierViewall">In conclusion, the current study has shown that administration of EPO is effective in resolving the established chronic histopathological changes of lungs in a murine model of asthma. Further studies with long-term treatments which evaluate the effects of EPO on lung inflammation and remodelling are needed and especially the cytokine response for the EPO treatment in asthma should be investigated.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle">Conflict of interest</span><p id="par0135" class="elsevierStylePara elsevierViewall">The authors have no conflict of interest to declare.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:2 [ "identificador" => "xres86085" "titulo" => array:5 [ 0 => "Summary" 1 => "Background" 2 => "Methods" 3 => "Results" 4 => "Conclusions" ] ] 1 => array:2 [ "identificador" => "xpalclavsec74248" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0010" "titulo" => "Materials and methods" "secciones" => array:5 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Experimental animals" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Sensitisation and inhalational exposure" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "Study drugs" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Histopathological analysis" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Statistical analysis" ] ] ] 4 => array:2 [ "identificador" => "sec0040" "titulo" => "Results" ] 5 => array:2 [ "identificador" => "sec0045" "titulo" => "Discussion" ] 6 => array:2 [ "identificador" => "sec0050" "titulo" => "Conflict of interest" ] 7 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2011-01-03" "fechaAceptado" => "2011-02-14" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec74248" "palabras" => array:4 [ 0 => "Chronic asthma" 1 => "Erythropoietin" 2 => "Mouse" 3 => "Treatment" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Summary" "resumen" => "<span class="elsevierStyleSectionTitle">Background</span><p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Erythropoietin (EPO) is originally defined as a haematopoietic growth factor, but also has anti-inflammatory effects through cytokine modulation. This anti-inflammatory and cytokine modulating effect has not been investigated for the treatment of asthma. We aimed to determine the beneficial effects of erythropoietin on lung histology of murine model of chronic asthma.</p> <span class="elsevierStyleSectionTitle">Methods</span><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Thirty-five BALB/c mice were divided into five groups: I; II; III; IV; and control group. All groups except control group were sensitised and challenged with ovalbumin. Mice with experimentally induced asthma in Group I received saline; Group II EPO 500<span class="elsevierStyleHsp" style=""></span>IU/kg; Group III EPO 1000<span class="elsevierStyleHsp" style=""></span>IU/kg; and Group IV dexamethasone 1<span class="elsevierStyleHsp" style=""></span>mg/kg intraperitoneally once a day in the last five days of the challenge period. Animals were sacrificed 24<span class="elsevierStyleHsp" style=""></span>h after the last administration of study drugs. Histological findings of airways were evaluated by light and electron microscopic examination.</p> <span class="elsevierStyleSectionTitle">Results</span><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">All histological parameters of asthma in the group treated with a high dose of EPO (Group III) were significantly ameliorated when compared with the group treated with saline (Group I). In comparison to the group treated with low dose of EPO (Group II) and the group treated with saline (Group I), basement membrane thicknesses and number of mast cells were significantly lower in the group treated with low dose of EPO (Group II). All histological parameters were similar between the group treated with high dose of EPO (Group III) and the group treated with dexamethasone (Group IV) except higher number of mast cells in the group treated with high dose of EPO (Group III). Additionally, the results of all histological parameters in the group treated with high dose of EPO (Group III) were significantly better when compared with the group treated with low dose of EPO (Group II).</p> <span class="elsevierStyleSectionTitle">Conclusions</span><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">We found that EPO ameliorated histological changes of chronic murine model of asthma. Further studies are needed to evaluate the efficacy of EPO in the treatment of asthma.</p>" ] ] "multimedia" => array:4 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 764 "Ancho" => 2354 "Tamanyo" => 100628 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Murine model of airway inflammation and treatment with EPO.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 2090 "Ancho" => 3347 "Tamanyo" => 1083536 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Light and electron microscopic findings of Groups. I; control, II; asthma, III; EPO (500<span class="elsevierStyleHsp" style=""></span>IU/kg), IV; EPO (1000<span class="elsevierStyleHsp" style=""></span>IU/kg), V; Dexa group. In representative histological images, lung tissues were stained with H&E (a; 1st row), PAS (b; 2nd row) and toluidine blue (c; 3rd row). In control group; light microscopic findings (Ia) revealed a regular respiratory epithelium and airways (Av), a thin, regular subepithelial smooth muscle layer (arrow with two heads), and normal PAS-stained parenchymal structures (Ib). Parenchymal structures with toluidine blue staining were regular (Ic). Electron microscopy (Id) revealed goblet cells (Gc), and healthy epithelial cells with cilia (C). The basement membrane was thin and regular (*), and there were two to three layers of subepithelial smooth muscle cells (Sm). In asthma group; H&E staining (IIa) revealed thickened epithelium, thickened subepithelial smooth muscle (arrow with two heads), and peribronchial mononuclear infiltration (*). High numbers of goblet cells (Gc) were seen with PAS-staining (IIb), and mast cells with toluidine blue staining (IIc). In dexa group; no difference in light microscopic findings was found compared with control rats (Va, Vb, Vc and Vd), In EPO (500<span class="elsevierStyleHsp" style=""></span>IU/kg) and EPO (1000<span class="elsevierStyleHsp" style=""></span>IU/kg) groups; the pathological changes, cellular infiltration around airways, goblet cell hyperplasia and number of mast cells, were significantly less than in asthma group. Electron microscopic findings revealed a thickened basement membrane (*) and smooth muscle cells (Sm) in asthma group (IId). Healthy respiratory epithelium with cilia (C) and goblet cells (Gc) in EPO (500<span class="elsevierStyleHsp" style=""></span>IU/kg) (IIId), EPO (1000<span class="elsevierStyleHsp" style=""></span>IU/kg) (IVd) and dexa (Vd) groups.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Control (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Asthma (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"><span class="elsevierStyleItalic">p</span> \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Basement membrane thickness (nm) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">272.61<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>19.14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">662.05<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>33.17 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Subepithelial smooth muscle thickness (μm) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4.67<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11.27<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.64 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Epithelium thickness (μm) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">38.91<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.99 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">50.96<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.61 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Number of mast cells/16,400 (μm<span class="elsevierStyleSup">2</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.32<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.12 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.75<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.20 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Number of goblet cells/100 (μm<span class="elsevierStyleSup">2</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.72<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.99<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.40 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><0.05 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab165431.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Comparison between asthma (Group I) and control groups.</p>" ] ] 3 => array:7 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Erythropoietin (500<span class="elsevierStyleHsp" style=""></span>IU/kg)Group II (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Erythropoietin (1000<span class="elsevierStyleHsp" style=""></span>IU/kg)Group III (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Dexamethasone (1<span class="elsevierStyleHsp" style=""></span>mg/kg)Group IV (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">AsthmaGroup I (mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD) \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Basement membrane thickness (nm) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">580.56<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>10.53<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a><span class="elsevierStyleSup">,**</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">503.96<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>12.68<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">**</span></a><span class="elsevierStyleSup">*</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">518.29<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>30.18<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">662.05<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>33.17 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Subepithelial smooth muscle thickness (μm) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">10.90<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.42<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">**</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">8.10<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.50<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a><span class="elsevierStyleSup">,**,***</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">7.49<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.14<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">11.27<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.64 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Epithelium thickness (μm) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">48.82<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.66<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">**</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">43.10<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.58<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a><span class="elsevierStyleSup">,***</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">41.07<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>3.09<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">50.96<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.61 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Number of mast cells/16,400 (μm<span class="elsevierStyleSup">2</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.92<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.21<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.63<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.22<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">**</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#tblfn0015"><span class="elsevierStyleSup">***</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.92<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.17<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.75<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.20 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Number of goblet cells/100 (μm<span class="elsevierStyleSup">2</span>) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.51<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.30<a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">**</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.11<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.01<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a><span class="elsevierStyleSup">,</span><a class="elsevierStyleCrossRef" href="#tblfn0010"><span class="elsevierStyleSup">**</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.12<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.17<a class="elsevierStyleCrossRef" href="#tblfn0005"><span class="elsevierStyleSup">*</span></a> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="char" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.99<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>0.40 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab165432.png" ] ] ] "notaPie" => array:3 [ 0 => array:3 [ "identificador" => "tblfn0005" "etiqueta" => "*" "nota" => "<p class="elsevierStyleNotepara"><span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 in groups versus placebo (asthma).</p>" ] 1 => array:3 [ "identificador" => "tblfn0010" "etiqueta" => "**" "nota" => "<p class="elsevierStyleNotepara"><span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 in groups versus dexamethasone.</p>" ] 2 => array:3 [ "identificador" => "tblfn0015" "etiqueta" => "***" "nota" => "<p class="elsevierStyleNotepara"><span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 in groups treated with two different doses of EPO.</p>" ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Comparison between study groups.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:31 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Novel drugs for treating asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "T.T. Hansel" 1 => "P.J. Barnes" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Curr Allergy Asthma Rep" "fecha" => "2001" "volumen" => "1" "paginaInicial" => "164" "paginaFinal" => "173" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11899299" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Understanding airway wall remodeling in asthma: a basis for improvements in therapy?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "R.K. Kumar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Pharmacol Ther" "fecha" => "2001" "volumen" => "91" "paginaInicial" => "93" "paginaFinal" => "104" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11728603" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mechanisms of airway remodeling in asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "E. Tagaya" 1 => "J. Tamaoki" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Allergol Int" "fecha" => "2007" "volumen" => "56" "paginaInicial" => "33" "paginaFinal" => "340" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Airway wall remodelling: does it occur and what does it mean?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "J.C. Kips" 1 => "R.A. Paulwels" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Exp Allergy" "fecha" => "1999" "volumen" => "29" "paginaInicial" => "1457" "paginaFinal" => "1466" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10520072" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Airway remodeling in asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "Y. Sumi" 1 => "Q. Hamid" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2332/allergolint.R-07-153" "Revista" => array:6 [ "tituloSerie" => "Allergol Int" "fecha" => "2007" "volumen" => "56" "paginaInicial" => "341" "paginaFinal" => "348" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17965577" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Early thickening of the reticular basement membrane in children with difficult asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.N. Payne" 1 => "A.V. Rogers" 2 => "E. Adelroth" 3 => "V. Bandi" 4 => "K.K. Guntupalli" 5 => "A. Bush" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1164/rccm.200205-414OC" "Revista" => array:6 [ "tituloSerie" => "Am J Respir Crit Care Med" "fecha" => "2003" "volumen" => "167" "paginaInicial" => "78" "paginaFinal" => "82" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12502479" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The non-haematopoietic biological effects of erythropoietin" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "M.O. Arcasoy" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2141.2008.07014.x" "Revista" => array:6 [ "tituloSerie" => "Br J Haematol" "fecha" => "2008" "volumen" => "141" "paginaInicial" => "14" "paginaFinal" => "31" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18324962" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "F.M. Bany-Mohammad" 1 => "S. Slivka" 2 => "M. Hallman" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1203/00006450-199609000-00003" "Revista" => array:6 [ "tituloSerie" => "Pediatr Res" "fecha" => "1996" "volumen" => "40" "paginaInicial" => "381" "paginaFinal" => "387" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8865272" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inhibition of angiogenesis decreases alveolarization in the developing rat lung" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Jakkula" 1 => "T.D. Le Cras" 2 => "S. Gebb" 3 => "K.P. Hirth" 4 => "R.M. Tuder" 5 => "N.F. Voelkel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Am J Physiol Lung Cell Mol Physiol" "fecha" => "2000" "volumen" => "279" "paginaInicial" => "600" "paginaFinal" => "607" ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin effects on dendritic cells: potential mediators in its function as an immunomodulator?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Prutchi Sagiv" 1 => "L. Lifshitz" 2 => "R. Orkin" 3 => "M. Mittelman" 4 => "D. Neumann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.exphem.2008.07.010" "Revista" => array:7 [ "tituloSerie" => "Exp Hematol" "fecha" => "2008" "volumen" => "36" "paginaInicial" => "1682" "paginaFinal" => "1690" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18922618" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0015028204029929" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin inhibits cytokine production of neonatal and adult leukocytes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "T. Strunk" 1 => "C. Härtel" 2 => "P. Temming" 3 => "N. Matzke" 4 => "J. Zimmer" 5 => "C. Schultz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1651-2227.2007.00560.x" "Revista" => array:6 [ "tituloSerie" => "Acta Paediatr" "fecha" => "2008" "volumen" => "97" "paginaInicial" => "16" "paginaFinal" => "20" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18052997" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methocholine responsiveness following chronic exposure to aerosolised allergen" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Temelkovski" 1 => "S.P. Hogan" 2 => "D.P. Shepherd" 3 => "P.S. Foster" 4 => "R.K. Kumar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "1998" "volumen" => "53" "paginaInicial" => "849" "paginaFinal" => "856" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10193371" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy of sulphasalazine on lung histopathology in a murine model of chronic asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Olmez" 1 => "A. Babayigit" 2 => "N. Uzuner" 3 => "G. Erbil" 4 => "O. Karaman" 5 => "O. Yilmaz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1080/01902140802271859" "Revista" => array:6 [ "tituloSerie" => "Exp Lung Res" "fecha" => "2008" "volumen" => "34" "paginaInicial" => "501" "paginaFinal" => "511" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18850376" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recombinant human erythropoietin reduces epithelial cell apoptosis and attenuates bleomycin-induced pneumonitis in mice" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Yoshimi" 1 => "T. Maeyama" 2 => "M. Yamada" 3 => "N. Hamada" 4 => "J. Fukumoto" 5 => "T. Kawaguchi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1440-1843.2008.01324.x" "Revista" => array:6 [ "tituloSerie" => "Respirology" "fecha" => "2008" "volumen" => "13" "paginaInicial" => "639" "paginaFinal" => "645" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18713087" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Anti-inflammatory effects of erythropoietin on hyperoxia-induced bronchopulmonary dysplasia in newborn rats" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "X.L. Wang" 1 => "X.D. Xue" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Zhonghua Er Ke Za Zhi" "fecha" => "2009" "volumen" => "47" "paginaInicial" => "446" "paginaFinal" => "451" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19951473" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Structural changes in airway diseases: characteristics, mechanisms, consequences, and pharmacologic modulation" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "C. Bergeron" 1 => "L.P. Boulet" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1378/chest.129.4.1068" "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2006" "volumen" => "129" "paginaInicial" => "1068" "paginaFinal" => "1087" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16608960" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Asthma therapy and airway remodeling" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "T. Mauad" 1 => "E.H. Bel" 2 => "P.J. Sterk" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2007.06.031" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2007" "volumen" => "120" "paginaInicial" => "997" "paginaFinal" => "1009" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17681364" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Airway remodeling in asthma and irreversible airflow limitation—ECM deposition in airway and possible therapy for remodeling" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "K. Yamauchi" 1 => "H. Inoue" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2332/allergolint.R-07-151" "Revista" => array:6 [ "tituloSerie" => "Allergol Int" "fecha" => "2007" "volumen" => "56" "paginaInicial" => "321" "paginaFinal" => "329" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17965575" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Specificity of basement membrane thickening in severe asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "A. Bourdin" 1 => "D. Neveu" 2 => "I. Vachier" 3 => "F. Paganin" 4 => "P. Godard" 5 => "P. Chanez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaci.2007.01.055" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol" "fecha" => "2007" "volumen" => "119" "paginaInicial" => "1367" "paginaFinal" => "1374" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17481707" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Apoptosis and hematopoiesis in murine fetal liver" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "H. Yu" 1 => "B. Bauer" 2 => "G.K. Lipke" 3 => "R.L. Phillips" 4 => "G. Van Zant" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Blood" "fecha" => "1993" "volumen" => "81" "paginaInicial" => "373" "paginaFinal" => "384" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/7678514" "web" => "Medline" ] ] ] ] ] ] ] ] 20 => array:3 [ "identificador" => "bib0105" "etiqueta" => "21" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Crawford" 1 => "D. Cella" 2 => "C.S. Cleeland" 3 => "P.Y. Cremieux" 4 => "G.D. Demetri" 5 => "B.J. Sarokhan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/cncr.10763" "Revista" => array:7 [ "tituloSerie" => "Cancer" "fecha" => "2002" "volumen" => "95" "paginaInicial" => "888" "paginaFinal" => "895" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12209734" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0735109796005633" "estado" => "S300" "issn" => "07351097" ] ] ] ] ] ] ] 21 => array:3 [ "identificador" => "bib0110" "etiqueta" => "22" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Dzietko" 1 => "U. Felderhoff-Mueser" 2 => "M. Sifringer" 3 => "B. Krutz" 4 => "P. Bittigau" 5 => "F. Thor" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.nbd.2003.10.006" "Revista" => array:6 [ "tituloSerie" => "Neurobiol Dis" "fecha" => "2004" "volumen" => "15" "paginaInicial" => "177" "paginaFinal" => "187" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15006687" "web" => "Medline" ] ] ] ] ] ] ] ] 22 => array:3 [ "identificador" => "bib0115" "etiqueta" => "23" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin inhibits spinal neuronal apoptosis and pain following nerve root crush" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "Y. Sekiguchi" 1 => "S. Kikuchi" 2 => "R.R. Myers" 3 => "W.M. Campana" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1097/01.BRS.0000096674.12519.12" "Revista" => array:6 [ "tituloSerie" => "Spine" "fecha" => "2003" "volumen" => "28" "paginaInicial" => "2577" "paginaFinal" => "2584" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14652474" "web" => "Medline" ] ] ] ] ] ] ] ] 23 => array:3 [ "identificador" => "bib0120" "etiqueta" => "24" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Calvillo" 1 => "R. Latini" 2 => "J. Kajstura" 3 => "A. Leri" 4 => "P. Anversa" 5 => "P. Ghezzi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.0630444100" "Revista" => array:6 [ "tituloSerie" => "Proc Natl Acad Sci" "fecha" => "2003" "volumen" => "100" "paginaInicial" => "4802" "paginaFinal" => "4806" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/12663857" "web" => "Medline" ] ] ] ] ] ] ] ] 24 => array:3 [ "identificador" => "bib0125" "etiqueta" => "25" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin protects against ischemic acute renal injury" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.A. Vesey" 1 => "C. Cheung" 2 => "B. Pat" 3 => "Z. Endre" 4 => "G. Gobé" 5 => "D.W. Johnson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Nephrol Dial Transpl" "fecha" => "2004" "volumen" => "19" "paginaInicial" => "348" "paginaFinal" => "355" ] ] ] ] ] ] 25 => array:3 [ "identificador" => "bib0130" "etiqueta" => "26" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "M. Brines" 1 => "A. Cerami" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/sj.ki.5001546" "Revista" => array:7 [ "tituloSerie" => "Kidney Int" "fecha" => "2006" "volumen" => "70" "paginaInicial" => "246" "paginaFinal" => "250" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16738535" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0015028202048549" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 26 => array:3 [ "identificador" => "bib0135" "etiqueta" => "27" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The role of nuclear factor-kappa B in pulmonary diseases" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "J.W. Christman" 1 => "R.T. Sadikot" 2 => "T.S. Blackwell" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Chest" "fecha" => "2000" "volumen" => "117" "paginaInicial" => "1482" "paginaFinal" => "1487" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10807839" "web" => "Medline" ] ] ] ] ] ] ] ] 27 => array:3 [ "identificador" => "bib0140" "etiqueta" => "28" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Desmet" 1 => "P. Gosset" 2 => "B. Pajak" 3 => "D. Cataldo" 4 => "M. Bentires-Alj" 5 => "P. Lekeux" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Immunol" "fecha" => "2004" "volumen" => "173" "paginaInicial" => "5766" "paginaFinal" => "5775" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15494529" "web" => "Medline" ] ] ] ] ] ] ] ] 28 => array:3 [ "identificador" => "bib0145" "etiqueta" => "29" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "R.J. Hancox" 1 => "D.A. Stevens" 2 => "I.M. Adcock" 3 => "P.J. Barnes" 4 => "D.R. Taylor" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Thorax" "fecha" => "1999" "volumen" => "54" "paginaInicial" => "488" "paginaFinal" => "492" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/10335001" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0015028299004847" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 29 => array:3 [ "identificador" => "bib0150" "etiqueta" => "30" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin contrastingly affects bacterial infection and experimental colitis by inhibiting nuclear factor-κB-inducible immune pathways" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Nairz" 1 => "A. Schroll" 2 => "A.R. Moschen" 3 => "T. Sonnweber" 4 => "M. Theurl" 5 => "I. Theurl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.immuni.2011.01.002" "Revista" => array:7 [ "tituloSerie" => "Immunity" "fecha" => "2011" "volumen" => "34" "paginaInicial" => "61" "paginaFinal" => "74" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21256055" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0015028204028663" "estado" => "S300" "issn" => "00150282" ] ] ] ] ] ] ] 30 => array:3 [ "identificador" => "bib0155" "etiqueta" => "31" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Cuzzocrea" 1 => "E. Mazzon" 2 => "R. di Paola" 3 => "T. Genovese" 4 => "N.S. Patel" 5 => "D. Britti" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/art.20875" "Revista" => array:6 [ "tituloSerie" => "Arthritis Rheum" "fecha" => "2005" "volumen" => "52" "paginaInicial" => "940" "paginaFinal" => "950" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15751086" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/03010546/0000004000000002/v1_201304101104/S0301054611001534/v1_201304101104/en/main.assets" "Apartado" => array:4 [ "identificador" => "5554" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Original articles" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/03010546/0000004000000002/v1_201304101104/S0301054611001534/v1_201304101104/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0301054611001534?idApp=UINPBA00004N" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 2 | 0 | 2 |
2024 October | 9 | 6 | 15 |
2024 September | 20 | 14 | 34 |
2024 August | 24 | 16 | 40 |
2024 July | 26 | 15 | 41 |
2024 June | 24 | 15 | 39 |
2024 May | 19 | 12 | 31 |
2024 April | 19 | 6 | 25 |
2024 March | 37 | 7 | 44 |
2024 February | 15 | 3 | 18 |
2024 January | 23 | 7 | 30 |
2023 December | 26 | 14 | 40 |
2023 November | 21 | 36 | 57 |
2023 October | 34 | 16 | 50 |
2023 September | 38 | 11 | 49 |
2023 August | 23 | 7 | 30 |
2023 July | 15 | 4 | 19 |
2023 June | 24 | 4 | 28 |
2023 May | 60 | 4 | 64 |
2023 April | 59 | 4 | 63 |
2023 March | 48 | 2 | 50 |
2023 February | 33 | 6 | 39 |
2023 January | 48 | 8 | 56 |
2022 December | 35 | 5 | 40 |
2022 November | 18 | 6 | 24 |
2022 October | 29 | 11 | 40 |
2022 September | 27 | 10 | 37 |
2022 August | 27 | 9 | 36 |
2022 July | 24 | 9 | 33 |
2022 June | 12 | 7 | 19 |
2022 May | 26 | 16 | 42 |
2022 April | 19 | 10 | 29 |
2022 March | 21 | 9 | 30 |
2022 February | 15 | 9 | 24 |
2022 January | 19 | 10 | 29 |
2021 December | 31 | 15 | 46 |
2021 November | 14 | 17 | 31 |
2021 October | 32 | 14 | 46 |
2021 September | 16 | 14 | 30 |
2021 August | 9 | 17 | 26 |
2021 July | 13 | 10 | 23 |
2021 June | 12 | 12 | 24 |
2021 May | 17 | 18 | 35 |
2021 April | 30 | 38 | 68 |
2021 March | 11 | 23 | 34 |
2021 February | 6 | 18 | 24 |
2021 January | 9 | 10 | 19 |
2020 December | 0 | 7 | 7 |
2020 November | 0 | 4 | 4 |
2020 October | 0 | 1 | 1 |
2020 September | 0 | 1 | 1 |
2020 August | 0 | 4 | 4 |
2020 July | 0 | 4 | 4 |
2020 June | 0 | 2 | 2 |
2020 May | 0 | 6 | 6 |
2020 April | 0 | 2 | 2 |
2020 March | 0 | 3 | 3 |
2020 February | 0 | 1 | 1 |
2020 January | 0 | 3 | 3 |
2019 December | 0 | 4 | 4 |
2019 November | 0 | 3 | 3 |
2019 October | 0 | 1 | 1 |
2019 September | 0 | 2 | 2 |
2019 July | 0 | 2 | 2 |
2019 June | 0 | 18 | 18 |
2019 May | 0 | 54 | 54 |
2019 April | 0 | 9 | 9 |
2018 February | 8 | 3 | 11 |
2018 January | 16 | 0 | 16 |
2017 December | 8 | 3 | 11 |
2017 November | 13 | 2 | 15 |
2017 October | 13 | 1 | 14 |
2017 September | 8 | 2 | 10 |
2017 August | 9 | 5 | 14 |
2017 July | 10 | 1 | 11 |
2017 June | 30 | 11 | 41 |
2017 May | 14 | 11 | 25 |
2017 April | 19 | 5 | 24 |
2017 March | 12 | 25 | 37 |
2017 February | 18 | 5 | 23 |
2017 January | 6 | 1 | 7 |
2016 December | 11 | 7 | 18 |
2016 November | 32 | 6 | 38 |
2016 October | 27 | 12 | 39 |
2016 September | 28 | 5 | 33 |
2016 August | 17 | 8 | 25 |
2016 July | 9 | 1 | 10 |
2016 June | 22 | 8 | 30 |
2016 May | 16 | 6 | 22 |
2016 April | 15 | 13 | 28 |
2016 March | 18 | 12 | 30 |
2016 February | 16 | 13 | 29 |
2016 January | 19 | 13 | 32 |
2015 December | 11 | 11 | 22 |
2015 November | 14 | 6 | 20 |
2015 October | 25 | 4 | 29 |
2015 September | 15 | 3 | 18 |
2015 August | 38 | 1 | 39 |
2015 July | 31 | 3 | 34 |
2015 June | 5 | 1 | 6 |
2015 May | 10 | 2 | 12 |
2015 April | 8 | 13 | 21 |
2015 March | 11 | 2 | 13 |
2015 February | 13 | 7 | 20 |
2015 January | 37 | 4 | 41 |
2014 December | 19 | 4 | 23 |
2014 November | 24 | 2 | 26 |
2014 October | 15 | 7 | 22 |
2014 September | 22 | 6 | 28 |
2014 August | 14 | 0 | 14 |
2014 July | 12 | 2 | 14 |
2014 June | 9 | 0 | 9 |
2014 May | 9 | 1 | 10 |
2014 April | 8 | 1 | 9 |
2014 March | 31 | 8 | 39 |
2014 February | 39 | 5 | 44 |
2014 January | 32 | 5 | 37 |
2013 December | 34 | 7 | 41 |
2013 November | 34 | 7 | 41 |
2013 October | 36 | 13 | 49 |
2013 September | 37 | 14 | 51 |
2013 August | 40 | 7 | 47 |
2013 July | 42 | 8 | 50 |
2013 June | 30 | 3 | 33 |
2013 May | 33 | 3 | 36 |
2013 April | 31 | 9 | 40 |
2013 March | 24 | 4 | 28 |
2013 February | 13 | 6 | 19 |
2013 January | 9 | 2 | 11 |
2012 December | 7 | 4 | 11 |
2012 November | 0 | 1 | 1 |
2012 October | 1 | 2 | 3 |
2012 September | 1 | 1 | 2 |
2012 March | 418 | 0 | 418 |